178 related articles for article (PubMed ID: 3709652)
1. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.
Winograd B; Lippens RJ; Oosterbaan MJ; Dirks MJ; Vree TB; van der Kleijn E
Eur J Clin Pharmacol; 1986; 30(2):231-8. PubMed ID: 3709652
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: relation to oral mucositis.
Albertioni F; Rask C; Schroeder H; Peterson C
Anticancer Drugs; 1997 Feb; 8(2):119-24. PubMed ID: 9073308
[TBL] [Abstract][Full Text] [Related]
4. Theoretically required urinary flow during high-dose methotrexate infusion.
Sasaki K; Tanaka J; Fujimoto T
Cancer Chemother Pharmacol; 1984; 13(1):9-13. PubMed ID: 6733846
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis.
Seideman P; Beck O; Eksborg S; Wennberg M
Br J Clin Pharmacol; 1993 Apr; 35(4):409-12. PubMed ID: 8485020
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.
Milano G; Thyss A; Renee N; Schneider M; Namer M; Boublil JL; Lalanne CM
Cancer Chemother Pharmacol; 1983; 11(1):29-32. PubMed ID: 6883624
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
8. Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate.
Fabresse N; Devictor B; Pissier C; Chambost H; Lacarelle B; Michel G; Solas C
Ther Drug Monit; 2018 Feb; 40(1):76-83. PubMed ID: 29120974
[TBL] [Abstract][Full Text] [Related]
9. Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method.
Beck O; Seideman P; Wennberg M; Peterson C
Ther Drug Monit; 1991 Nov; 13(6):528-32. PubMed ID: 1771651
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of the simultaneous detection of methotrexate and 7-hydroxymethotrexate in the delayed elimination for pediatric acute lymphoblastic leukemia].
Luo GJ; Wang L; Hu GF; Li CB; Liu HX; Peng MT
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1973-1978. PubMed ID: 32629599
[No Abstract] [Full Text] [Related]
11. The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy.
Lankelma J; van der Klein E; Ramaekers F
Cancer Lett; 1980 Apr; 9(2):133-42. PubMed ID: 7189691
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
Iven H; Brasch H; Engster J
Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
[TBL] [Abstract][Full Text] [Related]
13. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
Chen ML; Chiou WL
J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of 7-hydroxymethotrexate following medium-dose methotrexate therapy.
Stewart AL; Margison JM; Wilkinson PM; Lucas SB
Cancer Chemother Pharmacol; 1985; 14(2):165-7. PubMed ID: 3971482
[TBL] [Abstract][Full Text] [Related]
15. Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography.
Erttmann R; Bielack S; Landbeck G
Oncology; 1986; 43(2):86-8. PubMed ID: 3456549
[TBL] [Abstract][Full Text] [Related]
16. Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate.
Skoglund KA; Söderhäll S; Beck O; Peterson C; Wennberg M; Hayder S; Björk O
Med Pediatr Oncol; 1994; 22(3):187-93. PubMed ID: 8272008
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
Breithaupt H; Küenzlen E
Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
[TBL] [Abstract][Full Text] [Related]
19. Oral mucositis in children with acute lymphoblastic leukemia after high-dose methotrexate treatment without delayed elimination of methotrexate: relation to pharmacokinetic parameters of methotrexate.
Rask C; Albertioni F; Schrøder H; Peterson C
Pediatr Hematol Oncol; 1996; 13(4):359-67. PubMed ID: 8837142
[TBL] [Abstract][Full Text] [Related]
20. Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy.
Christophidis N; Louis WJ; Lucas I; Moon W; Vajda FJ
Cancer Chemother Pharmacol; 1981; 6(1):59-64. PubMed ID: 7273267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
